Benzinga
Benzinga
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
Benzinga
vendredi, octobre 30
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
Conmed Corp
CNMD
NYSE
Liste de surveillance
Get Report
Trade with Public
Get Report
Trade with Public
$45.72
-0.04
-0.09%
Dern. MÀJ: Oct 30, 5:20 AM
Get Report
Aperçu
Actualités
Prévisions de résultats
Événements
Objectifs de cours
Données financières
Sentiment
Actionnariat
Dividendes
Comparer
Rapport sur les stocks
Résultats:
Les résultats Q3 2026 ont été publiés le mer. oct. 28th, après la fermeture du marché
Conférence téléphonique:
La conférence téléphonique la plus récente a commencé à 4:30 PM, il y a 2 jours
Cliquez pour voir la webdiffusion
Conmed Financials
Conmed (CNMD) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
Conmed Raises FY2026 Adj EPS Guidance from $4.48-$4.60 to $4.54-$4.61 vs $4.54 Est; Narrows FY2026 Sales Guidance from $1.358B-$1.373B to $1.360B-$1.366B vs $1.366B Est
Conmed (NYSE:CNMD) raises FY2026 Adj EPS guidance from $4.48-$4.60 to $4.54-$4.61 vs $4.54 analyst estimate. Narrows FY2026 sales outlook from $1.358 billion-$1.373 billion to $1.360 billion-$1.366 billion vs $1.366
Benzinga Newsdesk
PRO
Conmed Q3 Adj. EPS $1.04 Beats $1.00 Estimate, Sales $335.557M Miss $336.226M Estimate
Conmed (NYSE:CNMD) reported quarterly earnings of $1.04 per share which beat the analyst consensus estimate of $1.00 by 4 percent. This is a 3.7 percent decrease over earnings of $1.08 per share from the same period
Benzinga Newsdesk
PRO
Conmed Sees FY2026 Adj EPS $4.48-$4.60 vs $4.34 Est; Narrows FY2026 Sales Guidance from $1.350B-$1.375B to $1.358B-$1.373B vs $1.362B Est
Conmed (NYSE:CNMD) is looking for FY2026 Adj EPS of $4.48-$4.60 vs $4.34 analyst estimate. Narrows FY2026 sales outlook from $1.350 billion-$1.375 billion to $1.358 billion-$1.373 billion vs $1.362 billion estimate.
Benzinga Newsdesk
PRO
Conmed Q2 Adj. EPS $1.38 Beats $1.11 Estimate, Sales $343.488M Beat $337.564M Estimate
Benzinga Newsdesk
PRO
Conmed Raises FY2026 Sales Guidance from $1.345B-$1.375B to $1.350B-$1.375B vs $1.359B Est
Conmed (NYSE:CNMD) raises FY2026 sales outlook from $1.345 billion-$1.375 billion to $1.350 billion-$1.375 billion vs $1.359 billion estimate.
Benzinga Newsdesk
PRO
Conmed Q1 Adj. EPS $0.89 Beats $0.82 Estimate, Sales $317.046M Beat $310.507M Estimate
Conmed (NYSE:CNMD) reported quarterly earnings of $0.89 per share which beat the analyst consensus estimate of $0.82 by 8.54 percent. This is a 6.32 percent decrease over earnings of $0.95 per share from the same period
Benzinga Newsdesk
